Login
$STRS
$19.32 +$0.00 (0.0%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
ASSETS
Cash and cash equivalents
Restricted cash
Real estate held for sale
Real estate under development
Land available for development
Real estate held for investment, net
Lease right-of-use assets
Deferred tax assets
Other assets
Asset, Held-for-Sale, Not Part of Disposal Group
Total assets
LIABILITIES AND EQUITY
Liabilities:
Accounts payable
Accrued liabilities, including taxes
Debt
Lease liabilities
Deferred gain
Other liabilities
Disposal Group, Including Discontinued Operation, Liabilities
Total liabilities
Equity:
Stockholders’ equity:
Common stock
Capital in excess of par value of common stock
Retained earnings
Common stock held in treasury
Total stockholders’ equity
Noncontrolling interests in subsidiaries
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support